Intraperitoneal chemotherapy: A reemerging approach in the treatment of ovarian cancer

Journal of Infusion Nursing

Volumn 32, Issue 6, 2009, Pages 314-322

  Drake, Barbie ^a  

^a Poudre Valley Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CREMOPHOR; PACLITAXEL; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ABDOMINAL PRESSURE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER REGRESSION; CLINICAL PROTOCOL; DRUG ABSORPTION; FATIGUE; HAIR LOSS; HUMAN; HYPOMAGNESEMIA; ILEUS; INFECTION; INFUSION SYSTEM; INTESTINAL BLEEDING; INTESTINE PERFORATION; MEMBRANE PERMEABILITY; MULTIPLE CYCLE TREATMENT; MYALGIA; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; OTOTOXICITY; OVARY CANCER; PATIENT CARE; PATIENT POSITIONING; PERITONEAL CATHETER; PERITONEAL CAVITY; PERITONEUM ADHESION; PRACTICE GUIDELINE; PREMEDICATION; PRIORITY JOURNAL; REGISTERED NURSE; REVIEW; VOMITING;

ANTINEOPLASTIC AGENTS; CHECKLIST; FEMALE; HUMANS; INFUSIONS, PARENTERAL; OVARIAN NEOPLASMS;

EID: 74249115105     PISSN: 15331458     EISSN: None     Source Type: Journal    
DOI: 10.1097/NAN.0b013e3181bd502f     Document Type: Review

References (18)

1. Marin K, Oleszewski K, Muehlbauer P. Intraperitoneal chemotherapy: implications beyond ovarian cancer. Clin J Oncol Nurs. 2007;11(6):881-887.
2. Almadrones L. Evidence-based research for intraperitoneal chemotherapy in epithelial ovarian cancer. Clin J Oncol Nurs. 2007;11(2):211-216.
3. Gynecological Oncology Group. IP chemotherapy: educational materials. http://www.gog.org/ipchemoed/ipchemoed.html. Accessed January 6, 2009.
4. Stuart O, Knight C, Sugarbaker P. Avoiding carcinogen exposure with intraperitoneal paclitaxel. Oncol Nurs Forum. 2005;32(1): 44-48.
5. Armstrong D, Bundy B, Wenzel L, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med. 2006;354: 34-43.
6. Itano J, Taoka K. Core Curriculum for Oncology Nursing. 4th ed. St Louis, MO: Elsevier Saunders; 2005:566-569.
7. Von Roenn J, ed. Your Guide to the Latest Cancer Research and Treatments: Highlights From the 2008 Annual Meeting of the American Society of Clinical Oncology. New York, NY: CancerCare; 2008.
8. Oestreicher P. Understand the benefits and risks of intraperitoneal therapy for advanced ovarian cancer. ONS Connect. 2007;22(4): 24-25.
9. Cancer Facts and Figures 2008. Atlanta, GA: American Cancer Society; 2008.
10. Martin V. Ovarian cancer: an overview of treatment options. Clin J Oncol Nurs. 2007;11(2):201-206.
11. National Cancer Institute. NCI Clinical Announcement: Intraperitoneal Chemotherapy for Ovarian Cancer. Bethesda, MD: National Cancer Institute, US National Institutes of Health; 2006.
12. Hydzik C. Implementation of intraperitoneal chemotherapy for the treatment of ovarian cancer. Clin J Oncol Nurs. 2007;11(2): 221-225.
13. Markman M, Walker J. Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment. J Clin Oncol. 2006;24(6):1-6.
14. Oncology Nursing Society. IP chemotherapy is making a comeback. ONS News. 2006;21(3):8.
15. Vergote I, Amant F, Leunen K, et al. Intraperitoneal chemotherapy in patients with advanced ovarian cancer: the con view. Oncologist. 2008;13(4):410-414.
16. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology™. Ovarian, Fallopian Tube and Primary Peritoneal Cancers. Version 2. Fort Washington, PA: National Comprehensive Cancer Network. 2009.
17. Cunningham D. Intraperitoneal chemotherapy standard of practice and procedures [serial online]. ONS Chemother Spec Interest Group Newslett. 2008;19(1). http://onsopcontent.ons.org/Publications/SigNewsletters/chemo/ chemo19.1.html. Accessed January 6, 2009.
18. Olson K. Hyperthermic intraperitoneal chemotherapy can give patients newfound hope [serial online]. ONS Surg Oncol Spec Interest Group Newslett. 2007;14(3). http://onsopcontent.ons.org/Publications/SigNewsletters/sonc/sonc14. 3.html. Accessed January 6, 2009.